|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 21, 2018 ) The Cystic Fibrosis Therapeutics Market is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide. It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR. The increasing prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, strong pipeline candidates, technological advancement and high rate of R&D initiatives are some of the major factors that are driving cystic fibrosis therapeutics market. However, high cost involved in treatment, increase in complexity of disease are restraining the cystic fibrosis therapeutics market.
Request a Sample of this Report @: http://orbisresearch.com/contacts/request-sample/468495
Scope of the Report:
Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Covered
1. Orkambi (Lumacaftor/Ivacaftor)
2. Kalydeco (Ivacaftor)
3. Cayston (Inhaled Aztreonam)
4. Pulmozyme (Dornase Alfa)
5. TOBI/ TOBI Podhaler
6. Creon
7. Zenpep
8. Ventolin
9. Bronchitol (Inhaled Mannitol)
10. ADEKplusTM
11. Ibuprofen
Global Cystic Fibrosis Therapeutics Market - Pharmacological Class
CFTR Modulators
Mucolytic Agents
Pancreatic Enzyme Replacement Products
Antibiotics
Other Therapies
Cystic Fibrosis Therapeutics Market – Geographical Analysis
1. United States
2. Canada
3. France
4. Germany
5. Italy
6. Spain
7. United Kingdom
8. Australia
9. Japan
10. China
11. India
12. South Korea
Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
1. Genentech, Inc. (A Member of the Roche Group)
2. Novartis
3. Gilead Sciences, Inc.
4. Vertex Pharmaceuticals Incorporated
5. AbbVie
6. GlaxoSmithKline
7. Johnson & Johnson
8. Allergan plc
9. Pharmaxis Ltd
10. Mylan N.V
Browse the Full Report@ : http://orbisresearch.com/reports/index/cystic-fibrosis-therapeutics-market-by-major-marketed-products-pharmacological-class-and-geography-and-pipeline-analysis-global-forecast-to-2024
Some of the Points cover in Report “Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, and Geography) and Pipeline Analysis-Global Forecast to 2024” is:
Executive Summary
Global Cystic Fibrosis Therapeutics Market & Forecast (2014 – 2024)
Global Cystic Fibrosis Therapeutics Market Share & Forecast
3.1 By Geography - Cystic Fibrosis Therapeutics Market Share & Forecast (2014 – 2024)
3.2 By Pharmacological Class - Cystic Fibrosis Therapeutics Market Share & Forecast (2015 – 2021)
Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast
4.1 Orkambi (Lumacaftor/Ivacaftor) Sales & Forecast (2015 – 2021)
4.2 Kalydeco (Ivacaftor) Sales & Forecast (2012 – 2021)
4.3 Cayston (Inhaled Aztreonam) Sales & Forecast (2010 – 2021)
4.4 Pulmozyme (Dornase Alfa) Sales & Forecast (2012 – 2021)
4.5 TOBI/ TOBI Podhaler Sales (2012 – 2016)
4.6 Creon Sales & Forecast (2011 – 2021)
4.7 Zenpep Sales & Forecast (2014 – 2021)
4.8 Ventolin Sales & Forecast (2012 – 2021)
4.9 Bronchitol (Inhaled Mannitol) Sales & Forecast (2013 – 2021)
4.10 ADEKplusTM
4.11 Ibuprofen
Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021)
5.1 CFTR Modulators Sales & Forecast
5.2 Mucolytic Agents Sales & Forecast
5.3 Pancreatic Enzyme Replacement Products Sales & Forecast
5.4 Antibiotics Sales & Forecast
5.5 Other Therapies Sales & Forecast
By Geography - Cystic Fibrosis Therapeutics Market (2014 – 2024)
Global Cystic Fibrosis Pipeline Product Analysis – By Company & Phase of Development
Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
8.1 Genentech, Inc. (A Member of the Roche Group)
8.2 Novartis
8.3 Gilead Sciences, Inc.
8.4 Vertex Pharmaceuticals Incorporated
8.5 AbbVie
8.6 GlaxoSmithKline
8.7 Johnson & Johnson
8.8 Allergan plc
8.9 Pharmaxis Ltd
8.10 Mylan N.V.
Global Cystic Fibrosis Market - Industry Trends & Developments
9.1 Genetic Testing
9.2 Technological Advances
9.3 CFTR Modulators - Gaining Momentum
9.4 Upsurge in the Number of Strategic Collaborations
9.5 Combination Therapy
9.6 Co-pay and Assistance Programs by Vendors
9.7 Increased R&D Activities: Drives Market Growth
Global Cystic Fibrosis Market – Growth Drivers
10.1 Robust Pipeline
10.2 Increasing Prevalence of Cystic Fibrosis
10.3 Improvement in Diagnostic Technologies
10.4 Unmet Medical Needs
Global Cystic Fibrosis Market – Challenges
Make an enquiry before buying this report : http://orbisresearch.com/contacts/enquiry-before-buying/468495
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
